Saturday, April 12 | 10:45–11:45 a.m.
Heidi Rehm, Ph.D., Massachusetts General Hospital & Broad Institute of MIT and Harvard
As genetic testing and the content of each test has expanded, so has the rate of VUSs. Tackling this bold challenge will require innovative efforts in building and aggregating evidence for classifying variants, improving knowledgebases, evolving standards for variant classification, and reconsidering when and how we report VUSs. This talk will touch on various aspects of this bold challenge and how we, as a community, will tackle these challenges collaboratively.
After attending this presentation, participants should be able to:
• Describe ways to reduce uncertainty in results returned to patients.
• Identify mechanisms to inform the pathogenicity of VUS.
The program includes sessions, networking opportunities, industry spotlights and more.
View program
